340
Participants
Start Date
February 17, 2020
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2025
Varenicline
Participants will receive open-label varenicline for 12 weeks.
Nicotine patch
Participants will receive open-label nicotine patch for 12 weeks. (Participants in the NMR-tailored treatment arms will receive either varenicline OR patch; they will not receive both)
Standard treatment
Standard behavioral smoking cessation treatment is an effective treatment for nicotine dependence. Treatment focuses on self-monitoring of smoking behavior, identifying smoking triggers and alternative trigger management strategies, relaxation, social support for non-smoking, and relapse prevention. Participants will receive up to 5 therapy sessions (2 in person, 3 over the phone) over 8 weeks.
Standard treatment + Managed Problem Solving (MAPS) adherence intervention
Standard behavioral smoking cessation treatment is an effective treatment for nicotine dependence. Treatment focuses on self-monitoring of smoking behavior, identifying smoking triggers and alternative trigger management strategies, relaxation, social support for non-smoking, and relapse prevention. Managed Problem Solving (MAPS) is a therapeutic process that involves the systematic delineation of a participant's medication adherence problems and construction of a series of individualized solutions that therapists and participants explore together. Participants will receive up to 5 therapy sessions (2 in person, 3 over the phone) over 8 weeks. The first session will directly address potential medication adherence barriers, and therapist and participant will collaboratively brainstorm ways to overcome these barriers.
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Northwestern University, Chicago
National Cancer Institute (NCI)
NIH
Northwestern University
OTHER
University of Pennsylvania
OTHER